Related Experiment Video
Updated: Jul 15, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
A deregulated m6A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA
Xiao Lu1, Lichao Peng1, Jiancheng Ding2
1State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.
Abstract:
Aberrant transcripts expression of the m6A methyltransferase complex (MTC) is widely found across human cancers, suggesting a dysregulated signaling cascade which integrates m6A epitranscriptome to drive tumorigenesis. However, the responsible transcriptional machinery directing the expression of distinct MTC subunits remains unclear. Here, we identified an unappreciated interplay between the histone acetyl-lysine reader BRD4 and the m6A writer complex across human cancers. BRD4 directly stimulates transcripts expression of seven MTC subunits, allowing the maintenance of the nuclear writer complex integrity. Upon BET inhibition, this BRD4-MTC signaling cascade accounts for global m6A reduction and the subsequent dynamic alteration of BRD4-dependent transcriptome, resulting in impaired DNA damage response that involves activation of homologous recombination (HR) repair and repression of apoptosis. We further demonstrated that the combined synergy upon BET/PARP inhibition largely relies on disrupted m6A modification of HR and apoptotic genes, counteracting PARP inhibitor (PARPi) resistance in patient-derived xenograft models. Our study revealed a widespread active cross-talk between BRD4-dependent epigenetic and MTC-mediated epitranscriptomic networks, which provides a unique therapeutic vulnerability that can be leveraged in combined DNA repair-targeted therapy.
Insights
BRD4 protein regulates the m6A writer complex, impacting cancer cell DNA repair and apoptosis. Targeting this pathway with BET and PARP inhibitors overcomes resistance in cancer treatment.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aberrant expression of the m6A methyltransferase complex (MTC) is linked to human cancers.
- The transcriptional regulation of MTC subunits and their role in tumorigenesis are not fully understood.
Purpose of the Study:
- To investigate the interplay between BRD4 and the m6A writer complex in cancer.
- To elucidate the functional consequences of this interaction on gene expression, DNA damage response, and therapeutic vulnerabilities.
Main Methods:
- Analysis of BRD4's role in regulating MTC subunit expression across cancers.
- Assessment of m6A modification dynamics upon BET inhibition.
- Evaluation of combined BET and PARP inhibition in patient-derived xenograft models.
Main Results:
- BRD4 directly stimulates the expression of seven MTC subunits, maintaining nuclear writer complex integrity.
- BET inhibition leads to global m6A reduction, altering BRD4-dependent transcription and impairing DNA damage response (homologous recombination repair and apoptosis).
- Combined BET/PARP inhibition disrupts m6A modification of key genes, overcoming PARP inhibitor resistance.
Conclusions:
- A significant cross-talk exists between BRD4-mediated epigenetic regulation and MTC-driven epitranscriptomic networks in cancer.
- This interplay presents a therapeutic vulnerability for combined DNA repair-targeted therapies.
- Targeting the BRD4-MTC axis offers a promising strategy to counteract PARP inhibitor resistance.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Base Excision Repair
The first step of...
Base-pairing and DNA Repair

